Cost of revenue · 2016–2022
Beone Medicines cost of revenue
$286M+73.7% · FY2022
Beone Medicines (ONC) reported $286M in cost of revenue for fiscal 2022, +73.7% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20222022-12-31 | $286M | +73.7% | Open → |
| FY20212021-12-31 | $165M | +133.4% | Open → |
| FY20202020-12-31 | $70.7M | −0.7% | Open → |
| FY20192019-12-31 | $71.2M | +148.0% | Open → |
| FY20182018-12-31 | $28.7M | +477.1% | Open → |
| FY20172017-12-31 | $5.0M | +$5.0M | Open → |
| FY20162016-12-31 | $0 | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Beone Medicines cost of revenue |url=https://companiesranked.com/en/company/beone-medicines/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Beone Medicines cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/beone-medicines/cost-of-revenueBibTeX
@misc{companiesranked-en-company-beone-medicines-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Beone Medicines cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/beone-medicines/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.